Table 1 Baseline characteristics of patients
Characteristics | No. of patients (%) |
|---|---|
All patients | 244 (100) |
Median age, years (min-max) | 51.3 (26.6–75.6) |
Stage | |
I | 111 (45.5) |
II | 93 (38.1) |
III | 40 (16.4) |
Tumor size, ≤2 cm | 49 (34.0) |
Positive lymph nodes status | 107 (43.9) |
Tumor grade | |
G1 | 18 (7.4) |
G2 | 143 (58.6) |
G3 | 59 (24.2) |
Unknown | 24 (9.8) |
Histology | |
Ductal infiltrating carcinoma | 212 (86.9) |
Other histology | 32 (14.1) |
Positive ER status (cut-off > 10%) | 154 (63.1) |
Positive PgRstatus(cut-off > 10%) | 137 (56.1) |
Ki67 positive status(cut-off > 14%) | 112 (45.9) |
Positive p53 status(cut-off ≥ 1%) | 34 (13.9) |
Positive HER2a(IHC/FISH) | 26 (10.7) |
Surgery | |
Conservative | 201 (82.4) |
Mastectomy | 43 (17.6) |
Adjuvant chemotherapy | |
CMF | 124 (50.8) |
FEC | 120 (49.2) |
Endocrine therapy | 148 (60.6) |
Radiotherapy | 205 (84.0) |